Molecular Partners AG: Key Insights from Form 6-K Filing on January 12, 2025

Here are the key insights extracted from the provided financial report section:

1. Filing Information:

• Type of Filing: Form 6-K
• Sequence Number: 1
• Filing Date: January 12, 2025
• Commission File Number: 001-40488

2. Company Details:

• Name: Molecular Partners AG
• Address: Wagistrasse 14, 8952 Zurich-Schlieren, Switzerland

3. Report Purpose:

• This Form 6-K is submitted as a foreign private issuer report under the Securities Exchange Act of 1934. It indicates that the registrant files annual reports under Form 20-F.

4. Content of the Filing:

• The registrant issued a press release on January 12, 2025, which is included as Exhibit 99.1.

5. Signature:

• The report is signed by Patrick Amstutz, the Chief Executive Officer of Molecular Partners AG, confirming the authenticity of the report.

6. Regulatory Compliance:

• The filing complies with Regulation S-T, which governs the submission of electronic documents to the SEC.

Summary:

This report serves as an official communication from Molecular Partners AG, fulfilling regulatory requirements for foreign private issuers. The attached press release may contain significant updates or announcements relevant to investors and stakeholders. The inclusion of the CEO's signature indicates the document's authenticity and compliance with SEC regulations.